BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 38240088)

  • 1. Bone marrow stromal cell antigen 2: Tumor biology, signaling pathway and therapeutic targeting (Review).
    Yu H; Bian Q; Wang X; Wang X; Lai L; Wu Z; Zhao Z; Ban B
    Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38240088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cells.
    Sayeed A; Luciani-Torres G; Meng Z; Bennington JL; Moore DH; Dairkee SH
    PLoS One; 2013; 8(6):e67191. PubMed ID: 23840623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.
    Cai D; Cao J; Li Z; Zheng X; Yao Y; Li W; Yuan Z
    BMC Cancer; 2009 Apr; 9():102. PubMed ID: 19338666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages.
    Leymarie O; Lepont L; Versapuech M; Judith D; Abelanet S; Janvier K; Berlioz-Torrent C
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BST2 Promotes Tumor Growth via Multiple Pathways in Hepatocellular Carcinoma.
    Xu X; Wang Y; Xue F; Guan E; Tian F; Xu J; Zhang H
    Cancer Invest; 2020 May; 38(5):329-337. PubMed ID: 32427495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow stromal cell antigen 2(BST2) suppresses the migration and invasion of trophoblasts in preeclampsia by downregulating matrix metallopeptidase 2(MMP2).
    Jinyu L; Shuying W; Panchan Z; Dan C; Chao C; Xingyu Y; Weiwei C
    Bioengineered; 2022 May; 13(5):13174-13187. PubMed ID: 35635087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study.
    Chiang SF; Kan CY; Hsiao YC; Tang R; Hsieh LL; Chiang JM; Tsai WS; Yeh CY; Hsieh PS; Liang Y; Chen JS; Yu JS
    Dis Markers; 2015; 2015():874054. PubMed ID: 26494939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer.
    Mukai S; Oue N; Oshima T; Mukai R; Tatsumoto Y; Sakamoto N; Sentani K; Tanabe K; Egi H; Hinoi T; Ohdan H; Yasui W
    Ann Surg Oncol; 2017 Feb; 24(2):594-602. PubMed ID: 26832883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer.
    Yokoyama T; Enomoto T; Serada S; Morimoto A; Matsuzaki S; Ueda Y; Yoshino K; Fujita M; Kyo S; Iwahori K; Fujimoto M; Kimura T; Naka T
    Int J Cancer; 2013 Jan; 132(2):472-84. PubMed ID: 22729361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATG5 selectively engages virus-tethered BST2/tetherin in an LC3C-associated pathway.
    Judith D; Versapuech M; Bejjani F; Palaric M; Verlhac P; Kuster A; Lepont L; Gallois-Montbrun S; Janvier K; Berlioz-Torrent C
    Proc Natl Acad Sci U S A; 2023 May; 120(20):e2217451120. PubMed ID: 37155854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BST2 suppresses porcine epidemic diarrhea virus replication by targeting and degrading virus nucleocapsid protein with selective autophagy.
    Kong N; Shan T; Wang H; Jiao Y; Zuo Y; Li L; Tong W; Yu L; Jiang Y; Zhou Y; Li G; Gao F; Yu H; Zheng H; Tong G
    Autophagy; 2020 Oct; 16(10):1737-1752. PubMed ID: 31868081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BST2 Mediates Osteoblast Differentiation via the BMP2 Signaling Pathway in Human Alveolar-Derived Bone Marrow Stromal Cells.
    Yoo SH; Kim JG; Kim BS; Lee J; Pi SH; Lim HD; Shin HI; Cho ES; You HK
    PLoS One; 2016; 11(6):e0158481. PubMed ID: 27359105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Expression of BTS-2 Enhances Cell Growth and Invasiveness in Renal Cell Carcinoma.
    Pham QT; Oue N; Yamamoto Y; Shigematsu Y; Sekino Y; Sakamoto N; Sentani K; Uraoka N; Tiwari M; Yasui W
    Anticancer Res; 2017 Jun; 37(6):2853-2860. PubMed ID: 28551621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the ILT7 receptor and plasmacytoid dendritic cell responses are governed by structurally-distinct BST2 determinants.
    Bego MG; Miguet N; Laliberté A; Aschman N; Gerard F; Merakos AA; Weissenhorn W; Cohen ÉA
    J Biol Chem; 2019 Jul; 294(27):10503-10518. PubMed ID: 31118237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of BST2 in human and experimental mouse brain tumors.
    Wainwright DA; Balyasnikova IV; Han Y; Lesniak MS
    Exp Mol Pathol; 2011 Aug; 91(1):440-6. PubMed ID: 21565182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane Anchoring by a C-terminal Tryptophan Enables HIV-1 Vpu to Displace Bone Marrow Stromal Antigen 2 (BST2) from Sites of Viral Assembly.
    Lewinski MK; Jafari M; Zhang H; Opella SJ; Guatelli J
    J Biol Chem; 2015 Apr; 290(17):10919-33. PubMed ID: 25759385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-functional BST2/tetherin against HIV-1, other viruses and LINE-1.
    Zhao Y; Zhao K; Wang S; Du J
    Front Cell Infect Microbiol; 2022; 12():979091. PubMed ID: 36176574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BST2 induced macrophage M2 polarization to promote the progression of colorectal cancer.
    He X; Chen H; Zhong X; Wang Y; Hu Z; Huang H; Zhao S; Wei P; Shi D; Li D
    Int J Biol Sci; 2023; 19(1):331-345. PubMed ID: 36594082
    [No Abstract]   [Full Text] [Related]  

  • 19. Activation of FGD5-AS1 Promotes Progression of Cervical Cancer through Regulating BST2 to Inhibit Macrophage M1 Polarization.
    Liu G; Du X; Xiao L; Zeng Q; Liu Q
    J Immunol Res; 2021; 2021():5857214. PubMed ID: 34692852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations accumulated in the Spike of SARS-CoV-2 Omicron allow for more efficient counteraction of the restriction factor BST2/Tetherin.
    Shi Y; Simpson S; Chen Y; Aull H; Benjamin J; Serra-Moreno R
    PLoS Pathog; 2024 Jan; 20(1):e1011912. PubMed ID: 38190411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.